Review





Similar Products

capture sequence h1 promoter paqci digestion site  (New England Biolabs)
96
New England Biolabs capture sequence h1 promoter paqci digestion site
Capture Sequence H1 Promoter Paqci Digestion Site, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/capture sequence h1 promoter paqci digestion site/product/New England Biolabs
Average 96 stars, based on 1 article reviews
capture sequence h1 promoter paqci digestion site - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
target captured dna  (Zymo Research)
90
Zymo Research target captured dna
Target Captured Dna, supplied by Zymo Research, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/target captured dna/product/Zymo Research
Average 90 stars, based on 1 article reviews
target captured dna - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
3 feature barcode capture sequence  (TaKaRa)
94
TaKaRa 3 feature barcode capture sequence
3 Feature Barcode Capture Sequence, supplied by TaKaRa, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/3 feature barcode capture sequence/product/TaKaRa
Average 94 stars, based on 1 article reviews
3 feature barcode capture sequence - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
whole exome capture  (Broad Clinical Labs)
95
Broad Clinical Labs whole exome capture
Whole Exome Capture, supplied by Broad Clinical Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/whole exome capture/product/Broad Clinical Labs
Average 95 stars, based on 1 article reviews
whole exome capture - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier
chromatin conformation capture sequencing hi c libraries  (Arima Genomics Inc)
93
Arima Genomics Inc chromatin conformation capture sequencing hi c libraries
Chromatin Conformation Capture Sequencing Hi C Libraries, supplied by Arima Genomics Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chromatin conformation capture sequencing hi c libraries/product/Arima Genomics Inc
Average 93 stars, based on 1 article reviews
chromatin conformation capture sequencing hi c libraries - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
hbv capture sequencing  (MyGenostics Inc)
90
MyGenostics Inc hbv capture sequencing
A Map of the CCDC91 gene with <t>HBV</t> DNA insertion in HCC (n = 17) and NHL (n = 1) tissues. Black arrows indicate HBV integration sites identified through pooled-analysis in HCC. Red arrows represent HBV integration sites detected in HCC samples using our HBV capture <t>sequencing</t> approach. Blue arrows denote HBV integration sites identified in non-Hodgkin lymphoma (NHL) samples from our previous HBV capture sequencing study. B Immunohistochemistry staining showed the protein expression of CCDC91 in 4 HBV capture sequencing HCC tissues. C The mRNA levels of CCDC91 in HCC tissues and non-cancerous liver tissues from GSEA cohorts ( GSE36376 : n = 193 in non-tumor, n = 240 in tumor; GSE76427 : n = 52 in non-tumor, n = 115 in tumor). D The mRNA levels of CCDC91 in HCC tissues and non-cancerous liver tissues from TCGA cohort (n = 50 in non-tumor, n = 371 in tumor). E Relative mRNA levels of CCDC91 in HCC cells as determined by qPCR (n = 3 independent biological repeats). F Representative IHC images of CCDC91 in HCC tissues and adjacent paratumor tissues (left) and IHC scores of CCDC91 staining in HCC tissues and non-cancerous liver tissues (right, n = 123). G The Kaplan–Meier analysis and log-rank test revealed the association of CCDC91 with the overall survival of HCC patients from TCGA dataset. H Multivariate logistic regression analyses for the associations of CCDC91 expression in HCC patients from TCGA dataset (n = 240). I Multivariate Cox regression analysis of the data from the TCGA dataset revealed that CCDC91 was an independent predictor of OS (n = 120). J The Kaplan–Meier analysis and log-rank test revealed the association of CCDC91 with the overall survival of HCC patients from TMA cohort (n = 123). K Multivariate logistic regression analyses for the associations of CCDC91 expression in HCC patients from TMA cohort (n = 80). Statistical analysis was performed using Student’s t test in ( C , D , E , and F ). Error bars represent the SEM. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
Hbv Capture Sequencing, supplied by MyGenostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hbv capture sequencing/product/MyGenostics Inc
Average 90 stars, based on 1 article reviews
hbv capture sequencing - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
10x genomics capture sequences cs1  (10X Genomics)
90
10X Genomics 10x genomics capture sequences cs1
A Map of the CCDC91 gene with <t>HBV</t> DNA insertion in HCC (n = 17) and NHL (n = 1) tissues. Black arrows indicate HBV integration sites identified through pooled-analysis in HCC. Red arrows represent HBV integration sites detected in HCC samples using our HBV capture <t>sequencing</t> approach. Blue arrows denote HBV integration sites identified in non-Hodgkin lymphoma (NHL) samples from our previous HBV capture sequencing study. B Immunohistochemistry staining showed the protein expression of CCDC91 in 4 HBV capture sequencing HCC tissues. C The mRNA levels of CCDC91 in HCC tissues and non-cancerous liver tissues from GSEA cohorts ( GSE36376 : n = 193 in non-tumor, n = 240 in tumor; GSE76427 : n = 52 in non-tumor, n = 115 in tumor). D The mRNA levels of CCDC91 in HCC tissues and non-cancerous liver tissues from TCGA cohort (n = 50 in non-tumor, n = 371 in tumor). E Relative mRNA levels of CCDC91 in HCC cells as determined by qPCR (n = 3 independent biological repeats). F Representative IHC images of CCDC91 in HCC tissues and adjacent paratumor tissues (left) and IHC scores of CCDC91 staining in HCC tissues and non-cancerous liver tissues (right, n = 123). G The Kaplan–Meier analysis and log-rank test revealed the association of CCDC91 with the overall survival of HCC patients from TCGA dataset. H Multivariate logistic regression analyses for the associations of CCDC91 expression in HCC patients from TCGA dataset (n = 240). I Multivariate Cox regression analysis of the data from the TCGA dataset revealed that CCDC91 was an independent predictor of OS (n = 120). J The Kaplan–Meier analysis and log-rank test revealed the association of CCDC91 with the overall survival of HCC patients from TMA cohort (n = 123). K Multivariate logistic regression analyses for the associations of CCDC91 expression in HCC patients from TMA cohort (n = 80). Statistical analysis was performed using Student’s t test in ( C , D , E , and F ). Error bars represent the SEM. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
10x Genomics Capture Sequences Cs1, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/10x genomics capture sequences cs1/product/10X Genomics
Average 90 stars, based on 1 article reviews
10x genomics capture sequences cs1 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
hybrid capture-based targeted next-generation sequencing ngs  (Illumina Inc)
90
Illumina Inc hybrid capture-based targeted next-generation sequencing ngs
A Map of the CCDC91 gene with <t>HBV</t> DNA insertion in HCC (n = 17) and NHL (n = 1) tissues. Black arrows indicate HBV integration sites identified through pooled-analysis in HCC. Red arrows represent HBV integration sites detected in HCC samples using our HBV capture <t>sequencing</t> approach. Blue arrows denote HBV integration sites identified in non-Hodgkin lymphoma (NHL) samples from our previous HBV capture sequencing study. B Immunohistochemistry staining showed the protein expression of CCDC91 in 4 HBV capture sequencing HCC tissues. C The mRNA levels of CCDC91 in HCC tissues and non-cancerous liver tissues from GSEA cohorts ( GSE36376 : n = 193 in non-tumor, n = 240 in tumor; GSE76427 : n = 52 in non-tumor, n = 115 in tumor). D The mRNA levels of CCDC91 in HCC tissues and non-cancerous liver tissues from TCGA cohort (n = 50 in non-tumor, n = 371 in tumor). E Relative mRNA levels of CCDC91 in HCC cells as determined by qPCR (n = 3 independent biological repeats). F Representative IHC images of CCDC91 in HCC tissues and adjacent paratumor tissues (left) and IHC scores of CCDC91 staining in HCC tissues and non-cancerous liver tissues (right, n = 123). G The Kaplan–Meier analysis and log-rank test revealed the association of CCDC91 with the overall survival of HCC patients from TCGA dataset. H Multivariate logistic regression analyses for the associations of CCDC91 expression in HCC patients from TCGA dataset (n = 240). I Multivariate Cox regression analysis of the data from the TCGA dataset revealed that CCDC91 was an independent predictor of OS (n = 120). J The Kaplan–Meier analysis and log-rank test revealed the association of CCDC91 with the overall survival of HCC patients from TMA cohort (n = 123). K Multivariate logistic regression analyses for the associations of CCDC91 expression in HCC patients from TMA cohort (n = 80). Statistical analysis was performed using Student’s t test in ( C , D , E , and F ). Error bars represent the SEM. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
Hybrid Capture Based Targeted Next Generation Sequencing Ngs, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hybrid capture-based targeted next-generation sequencing ngs/product/Illumina Inc
Average 90 stars, based on 1 article reviews
hybrid capture-based targeted next-generation sequencing ngs - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


A Map of the CCDC91 gene with HBV DNA insertion in HCC (n = 17) and NHL (n = 1) tissues. Black arrows indicate HBV integration sites identified through pooled-analysis in HCC. Red arrows represent HBV integration sites detected in HCC samples using our HBV capture sequencing approach. Blue arrows denote HBV integration sites identified in non-Hodgkin lymphoma (NHL) samples from our previous HBV capture sequencing study. B Immunohistochemistry staining showed the protein expression of CCDC91 in 4 HBV capture sequencing HCC tissues. C The mRNA levels of CCDC91 in HCC tissues and non-cancerous liver tissues from GSEA cohorts ( GSE36376 : n = 193 in non-tumor, n = 240 in tumor; GSE76427 : n = 52 in non-tumor, n = 115 in tumor). D The mRNA levels of CCDC91 in HCC tissues and non-cancerous liver tissues from TCGA cohort (n = 50 in non-tumor, n = 371 in tumor). E Relative mRNA levels of CCDC91 in HCC cells as determined by qPCR (n = 3 independent biological repeats). F Representative IHC images of CCDC91 in HCC tissues and adjacent paratumor tissues (left) and IHC scores of CCDC91 staining in HCC tissues and non-cancerous liver tissues (right, n = 123). G The Kaplan–Meier analysis and log-rank test revealed the association of CCDC91 with the overall survival of HCC patients from TCGA dataset. H Multivariate logistic regression analyses for the associations of CCDC91 expression in HCC patients from TCGA dataset (n = 240). I Multivariate Cox regression analysis of the data from the TCGA dataset revealed that CCDC91 was an independent predictor of OS (n = 120). J The Kaplan–Meier analysis and log-rank test revealed the association of CCDC91 with the overall survival of HCC patients from TMA cohort (n = 123). K Multivariate logistic regression analyses for the associations of CCDC91 expression in HCC patients from TMA cohort (n = 80). Statistical analysis was performed using Student’s t test in ( C , D , E , and F ). Error bars represent the SEM. *, p < 0.05; **, p < 0.01; ***, p < 0.001.

Journal: Communications Biology

Article Title: HBV DNA integration gene CCDC91 is oncogenic and a potential therapeutic target for hepatocellular carcinoma

doi: 10.1038/s42003-025-08369-1

Figure Lengend Snippet: A Map of the CCDC91 gene with HBV DNA insertion in HCC (n = 17) and NHL (n = 1) tissues. Black arrows indicate HBV integration sites identified through pooled-analysis in HCC. Red arrows represent HBV integration sites detected in HCC samples using our HBV capture sequencing approach. Blue arrows denote HBV integration sites identified in non-Hodgkin lymphoma (NHL) samples from our previous HBV capture sequencing study. B Immunohistochemistry staining showed the protein expression of CCDC91 in 4 HBV capture sequencing HCC tissues. C The mRNA levels of CCDC91 in HCC tissues and non-cancerous liver tissues from GSEA cohorts ( GSE36376 : n = 193 in non-tumor, n = 240 in tumor; GSE76427 : n = 52 in non-tumor, n = 115 in tumor). D The mRNA levels of CCDC91 in HCC tissues and non-cancerous liver tissues from TCGA cohort (n = 50 in non-tumor, n = 371 in tumor). E Relative mRNA levels of CCDC91 in HCC cells as determined by qPCR (n = 3 independent biological repeats). F Representative IHC images of CCDC91 in HCC tissues and adjacent paratumor tissues (left) and IHC scores of CCDC91 staining in HCC tissues and non-cancerous liver tissues (right, n = 123). G The Kaplan–Meier analysis and log-rank test revealed the association of CCDC91 with the overall survival of HCC patients from TCGA dataset. H Multivariate logistic regression analyses for the associations of CCDC91 expression in HCC patients from TCGA dataset (n = 240). I Multivariate Cox regression analysis of the data from the TCGA dataset revealed that CCDC91 was an independent predictor of OS (n = 120). J The Kaplan–Meier analysis and log-rank test revealed the association of CCDC91 with the overall survival of HCC patients from TMA cohort (n = 123). K Multivariate logistic regression analyses for the associations of CCDC91 expression in HCC patients from TMA cohort (n = 80). Statistical analysis was performed using Student’s t test in ( C , D , E , and F ). Error bars represent the SEM. *, p < 0.05; **, p < 0.01; ***, p < 0.001.

Article Snippet: HBV capture sequencing was conducted by MyGenostics (Beijing, China).

Techniques: Sequencing, Immunohistochemistry, Staining, Expressing